N/A
N=96
Postoperative Opioid Consumption in Gastric Sleeve Surgery
Obesity &Amp; Overweight · General Anesthetic · Ketamine
Bottom Line
View on ClinicalTrials.gov: NCT07135154 ↗Enrolled (actual)
96
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Morphine Equivalent Opioid Consumption — 40; 30 miligram
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Balikesir University
- Primary completion
- Mar 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Morphine Equivalent Opioid Consumption |
40; 30 | — |
| SECONDARY Postoperative Pain |
5; 5 | — |
Summary
The study aimed to compare balanced anesthesia protocols using only opioids as analgesics during induction in gastric sleeve surgery with protocols using opioids and ketamine together in terms of anesthesia management, opioid side effects, and postoperative analgesia.
Eligibility Criteria
Inclusion Criteria
Patients who have undergone gastric sleeve surgery Patients with mild systemic disease Patients with severe systemic disease that does not affect daily activities
Exclusion Criteria
Those with data loss in their files Those who do not use patient-controlled analgesia devices Patients who did not undergo standard anesthesia protocol
Data sourced from ClinicalTrials.gov (NCT07135154). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.